Physician profile
Daniel Garcia
NPI 1568475853
$8,779.33
in general payments reported to CMS, 2019-2025
12 companies · $1,467 in 2025
The $1,467 reported for 2025 was more than what 91% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,694 · 2020: $4,275 · 2022: $138 · 2023: $29.90 · 2024: $174 · 2025: $1,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,198 · Food and Beverage: $457 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,197.69 |
| Food and Beverage | $456.65 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $6,953.88 | 2019-2022 | |
| Intuitive Surgical, INC. | $1,197.69 | 2025 | |
| Genzyme Corporation | $180.15 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $115.74 | 2019 | |
| Harmony Biosciences LLC | $84.19 | 2024 | |
| Stryker Corporation | $56.89 | 2025 | Na |
| Baxter Healthcare | $48.49 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Glaxosmithkline, LLC. | $40.23 | 2019-2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $30.41 | 2025 | Dupixent |
| Azurity Pharmaceuticals, INC. | $30.18 | 2025 | Alvesco |
| Sanofi Pasteur INC. | $24.10 | 2025 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.